DexCom, Inc. (NASDAQ:DXCM) today announced that Steven Pacelli, Chief
Administrative Officer, will present an update on DexCom at the
Canaccord Adams Global Growth Conference in Boston on Tuesday, August
11, 2009 at 11:30 a.m. (EDT). The presentation, which will occur live at
The InterContinental Hotel in Boston, will be concurrently webcast. The
link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com
under the investor webcast section and will be archived for future
reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and
marketing continuous glucose monitoring systems for ambulatory use by
patients and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history.
Successful commercialization of the company’s products is subject to
numerous risks and uncertainties, including a lack of acceptance in the
marketplace by physicians and patients, the inability to manufacture
products in commercial quantities at an acceptable cost, possible delays
in the company’s development programs, the inability of patients to
receive reimbursement from third-party payors and inadequate financial
and other resources. Certain of these risks and uncertainties, in
addition to other risks, are more fully described in the company’s
annual report on Form 10-Q for the period ending June 30, 2009, as filed
with the Securities and Exchange Commission on August 3, 2009.
DexCom, Inc.
Steven R. Pacelli
Chief Administrative Officer
858-200-0200
